Prospective multicenter study regarding the efficacy of Gemcitabine (gemzar) plus nab-Paclitaxel (Abraxane) regimen for locally advanced pancreatic cancer
Phase 2
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000027775
- Lead Sponsor
- Kyushu-Yamaguchi study group of therapy for pancreatobiliary cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
1) Present or previous (within 5 years) double cancer except for carcinoma in situ 2) Pregnant females, possibly pregnant females, females feeding babies and males wishing partners' pregnancy 3) Active infection 4) Severe mental disorder 5) Interstitial pneumonia or pulmonary fibrosis 6) Severe heart disease, liver disease and uncontrolled diabetes 7) Patients positive for HBs antigen 8) Patients inadequate for enhanced CT scan 9) Severe allergy for drugs 10) Patients with inadequate condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method R0 resection rate
- Secondary Outcome Measures
Name Time Method QOL assessment, Effectiveness of preoperative chemotherapy, pathological response rate, incidence rate of adverse events, relative dose intensity